Ensoma
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease X-Linked Chronic Granulomatous Disease | Phase 1 / Phase 2 | 2025-08-05 |
| Recruiting | Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease Chronic Granulomatous Disease (CGD) | — | 2024-11-18 |
| Terminated | Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 2 | 2022-06-24 |
| Terminated | MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia | Phase 2 | 2021-06-16 |
| Completed | Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal I Healthy, Renal Insufficiency | Phase 1 | 2019-11-07 |
| Completed | Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2019-04-22 |